At a glance
- Originator Nonindustrial source
- Class Indoles
- Mechanism of Action Fibroblast growth factor inhibitors; Protein synthesis inhibitors; Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 13 May 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 16 Feb 1996 Preclinical development for Cancer in USA (Unknown route)